Increased MCP-1 gene expression in monocytes of severe OSA patients and under intermittent hypoxia

Sleep and Breathing

Volumn 20, Issue 1, 2016, Pages 425-433

  Chuang, Li Pang ^a,b   Chen, Ning Hung ^b   Lin, Yuling ^a   Ko, Wen Shan ^a   Pang, Jong Hwei S ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Intermittent hypoxia; Monocyte; Monocyte chemoattractant protein 1; Obstructive sleep apnea

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERMITTENT HYPOXIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SLEEP DISORDERED BREATHING; ATHEROSCLEROSIS; GENETICS; HYPOXIA; METABOLISM; POLYSOMNOGRAPHY; REFERENCE VALUE; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE;

ADULT; ATHEROSCLEROSIS; CHEMOKINE CCL2; FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA; MALE; MIDDLE AGED; MONOCYTES; POLYSOMNOGRAPHY; REFERENCE VALUES; RISK FACTORS; RNA, MESSENGER; SLEEP APNEA, OBSTRUCTIVE;

EID: 84961113424     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-015-1252-5     Document Type: Article

References (36)

1. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165(9):1217–1239
2. Malhotra A, White DP (2002) Obstructive sleep apnoea. Lancet 360(9328):237–245
3. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF (2001) Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154(1):50–59
4. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053
5. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98(21):2269–2275
6. Ryan S, McNicholas WT (2008) Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Arch Physiol Biochem 114(4):261–266. doi:10.1080/13813450802307337
7. Mestas J, Ley K (2008) Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 18(6):228–232. doi:10.1016/j.tcm.2008.11.004
8. Hansson GK (2009) Inflammatory mechanisms in atherosclerosis. J Thromb Haemost 7(Suppl 1):328–331. doi:10.1111/j.1538-7836.2009.03416.x
9. Amasyali B, Kose S, Kursaklioglu H, Barcin C, Kilic A (2009) Monocyte chemoattractant protein-1 in acute coronary syndromes: complex vicious interaction. Int J Cardiol 136(3):356–357. doi:10.1016/j.ijcard.2008.04.080
10. Green SR, Han KH, Chen Y, Almazan F, Charo IF, Miller YI, Quehenberger O (2006) The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J Immunol 176(12):7412–7420
11. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94(1):179–184. doi:10.1152/japplphysiol.00177.2002
12. Kim J, Lee CH, Park CS, Kim BG, Kim SW, Cho JH (2010) Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg 136(9):896–899. doi:10.1001/archoto.2010.142
13. Murao K, Imachi H, Yu X, Muraoka T, Hosami N, Dobashi H, Ishida T (2009) The transcriptional factor PREB mediates MCP-1 transcription induced by cytokines in human vascular endothelial cells. Atherosclerosis 207(1):45–50. doi:10.1016/j.atherosclerosis.2009.03.051
14. Chuang LP, Chen NH, Lin SW, Chang YL, Liao HR, Lin YS, Chao IJ, Lin Y, Pang JH (2014) Increased C-C chemokine receptor 2 gene expression in monocytes of severe obstructive sleep apnea patients and under intermittent hypoxia. PLoS One 9(11), e113304. doi:10.1371/journal.pone.0113304
15. Lavie L, Dyugovskaya L, Polyakov A (2008) Biology of peripheral blood cells in obstructive sleep apnea–the tip of the iceberg. Arch Physiol Biochem 114(4):244–254. doi:10.1080/13813450802306701
16. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M, Adachi M (2004) Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126(5):1473–1479. doi:10.1378/chest.126.5.1473
17. Glass CK, Witztum JL (2001) Atherosclerosis. The road ahead. Cell 104(4):503–516
18. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT (1994) Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90(2):775–778
19. Lavie L, Dyugovskaya L, Lavie P (2005) Sleep-apnea-related intermittent hypoxia and atherogenesis: adhesion molecules and monocytes/endothelial cells interactions. Atherosclerosis 183(1):183–184. doi:10.1016/j.atherosclerosis.2005.06.024
20. Tamaki S, Yamauchi M, Fukuoka A, Makinodan K, Koyama N, Tomoda K, Yoshikawa M, Kimura H (2009) Nocturnal hypoxic stress activates invasive ability of monocytes in patients with obstructive sleep apnoea syndrome. Respirology. doi:10.1111/j.1440-1843.2009.01540.x
21. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M (2003) Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 111(6):1185–1199, quiz 1200
22. Xu LL, Warren MK, Rose WL, Gong W, Wang JM (1996) Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol 60(3):365–371
23. Craig MJ, Loberg RD (2006) CCL2 (monocyte chemoattractant protein-1) in cancer bone metastases. Cancer Metastasis Rev 25(4):611–619. doi:10.1007/s10555-006-9027-x
24. Xia M, Sui Z (2009) Recent developments in CCR2 antagonists. Expert Opin Ther Pat 19(3):295–303. doi:10.1517/13543770902755129
25. Inoue S, Egashira K, Ni W, Kitamoto S, Usui M, Otani K, Ishibashi M, Hiasa K, Nishida K, Takeshita A (2002) Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106(21):2700–2706
26. Chuang SY, Yang SH, Pang JH (2011) Cilostazol reduces MCP-1-induced chemotaxis and adhesion of THP-1 monocytes by inhibiting CCR2 gene expression. Biochem Biophys Res Commun 411(2):402–408. doi:10.1016/j.bbrc.2011.06.163
27. Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7(12):677–685. doi:10.1038/nrcardio.2010.145
28. Morgan BJ (2007) Vascular consequences of intermittent hypoxia. Adv Exp Med Biol 618:69–84
29. Reale M, Di Giulio C, Cacchio M, Barbacane RC, Grilli A, Felaco M, Bianchi G, Di Gioacchino M, Conti P (2003) Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related. Mol Cell Biochem 248(1–2):1–6
30. Negus RP, Turner L, Burke F, Balkwill FR (1998) Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J Leukoc Biol 63(6):758–765
31. Tamaki S, Yamauchi M, Fukuoka A, Makinodan K, Koyama N, Tomoda K, Yoshikawa M, Kimura H (2009) Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern Med 48(15):1255–1262
32. Tamaki S, Yamauchi M, Fukuoka A, Makinodan K, Koyama N, Tomoda K, Yoshikawa M, Kimura H (2009) Nocturnal hypoxic stress activates invasive ability of monocytes in patients with obstructive sleep apnoea syndrome. Respirology 14(5):689–694. doi:10.1111/j.1440-1843.2009.01540.x
33. Chuang LP, Chen NH, Lin SW, Chang YL, Chao IJ, Pang JH (2013) Increased matrix metalloproteinases-9 after sleep in plasma and in monocytes of obstructive sleep apnea patients. Life Sci 93(5–6):220–225. doi:10.1016/j.lfs.2013.06.009
34. Burysek L, Syrovets T, Simmet T (2002) The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem 277(36):33509–33517. doi:10.1074/jbc.M201941200
35. Kim S, Joo YE (2011) Theaflavin inhibits LPS-induced IL-6, MCP-1, and ICAM-1 expression in bone marrow-derived macrophages through the blockade of NF-kappaB and MAPK signaling pathways. Chonnam Med J 47(2):104–110. doi:10.4068/cmj.2011.47.2.104
36. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 94(22):12053–12058